» Articles » PMID: 30156368

Theranostic Nanosensitizers for Highly Efficient MR/fluorescence Imaging-guided Sonodynamic Therapy of Gliomas

Overview
Journal J Cell Mol Med
Date 2018 Aug 30
PMID 30156368
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Glioma is the most frequent primary brain tumour of the central nervous system. Its high aggressiveness and deep-seated brain lesion make it a great challenge to develop a non-invasive, precise and effective treatment approach. Here, we report a multifunctional theranostic agent that can integrate imaging and therapy into a single nano-platform for imaging-guided sonodynamic therapy (SDT). The SDT agents were fabricated by encapsulation of sinoporphyrin sodium (DVDMS) chelating with manganese ions into nanoliposomes (DVDMS-Mn-LPs). DVDMS-Mn-LPs are physiologically stable and biologically compatible, and they can produce singlet oxygen upon ultrasound irradiation to kill cancer cells. Both cell and animal studies demonstrated that SDT with DVDMS-Mn-LPs can significantly improve the antitumour growth efficiency even in the presence of skull. In addition, DVDMS-Mn-LPs are good for MR and fluorescence imaging. Thus, DVDMS-Mn-LPs reported here may provide a promising strategy for imaging-guided modality for glioma treatment.

Citing Articles

Emerging nanoplatforms towards microenvironment-responsive glioma therapy.

Tripathy N, Sahoo L, Paikray S, Dilnawaz F Med Oncol. 2025; 42(2):46.

PMID: 39812745 DOI: 10.1007/s12032-024-02596-y.


Sonodynamic therapy for adult-type diffuse gliomas: past, present, and future.

Scanlon S, Shanahan R, Bin-Alamer O, Bouras A, Mattioli M, Huq S J Neurooncol. 2024; 169(3):507-516.

PMID: 39042302 DOI: 10.1007/s11060-024-04772-6.


.

Zhang Y, Luo Y, Zhao J, Zheng W, Zhan J, Zheng H Acta Pharm Sin B. 2024; 14(1):110-132.

PMID: 38239237 PMC: 10792979. DOI: 10.1016/j.apsb.2023.08.024.


Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions.

Wu D, Chen X, Zhou S, Li B Front Immunol. 2023; 14:1241791.

PMID: 37731484 PMC: 10507261. DOI: 10.3389/fimmu.2023.1241791.


Applications of Focused Ultrasound for the Treatment of Glioblastoma: A New Frontier.

Hersh A, Bhimreddy M, Weber-Levine C, Jiang K, Alomari S, Theodore N Cancers (Basel). 2022; 14(19).

PMID: 36230843 PMC: 9563027. DOI: 10.3390/cancers14194920.


References
1.
Zhang Z, Wang J, Chen C . Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. Adv Mater. 2013; 25(28):3869-80. DOI: 10.1002/adma.201301890. View

2.
Gallego Perez-Larraya J, Delattre J . Management of elderly patients with gliomas. Oncologist. 2014; 19(12):1258-67. PMC: 4257742. DOI: 10.1634/theoncologist.2014-0170. View

3.
Juratli T, Schackert G, Krex D . Current status of local therapy in malignant gliomas--a clinical review of three selected approaches. Pharmacol Ther. 2013; 139(3):341-58. DOI: 10.1016/j.pharmthera.2013.05.003. View

4.
Huang P, Qian X, Chen Y, Yu L, Lin H, Wang L . Metalloporphyrin-Encapsulated Biodegradable Nanosystems for Highly Efficient Magnetic Resonance Imaging-Guided Sonodynamic Cancer Therapy. J Am Chem Soc. 2016; 139(3):1275-1284. DOI: 10.1021/jacs.6b11846. View

5.
Yan X, Hu H, Lin J, Jin A, Niu G, Zhang S . Optical and photoacoustic dual-modality imaging guided synergistic photodynamic/photothermal therapies. Nanoscale. 2015; 7(6):2520-6. PMC: 5257288. DOI: 10.1039/c4nr06868h. View